IMUGENE CHART. TA only, page-29310

First I hold IMU and hope it succeeds but for all the pages and thousands of thumbs of from the supposed experts on here who write reams of posts, the cold hard facts are;
1. At this stage IMU is purely a retail stock with no big funds owning it. Just HC poster with hopes of multi returns
2. The big professional shorters of IMU hire proper cancer experts to analyse the data (not a few randoms on HC) - and they are building their shorts now. We will likely see cents or so (40% returns) as downside momentum builds. Still if you’re long term and hit a trader, you can ride out this IF they find the holy grail.